WASHINGTON, April 17 -- Food and Drug Administration has issued a notice called: Animal Generic Drug User Fee Act; Public Meeting; Request for Comments.
The notice was published in the Federal Register on April 17 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA, the Agency, or we) is announcing the following virtual public meeting entitled "Animal Generic Drug User Fee Act." The purpose of the public meeting is to invite public comment on the Animal Generic Drug User Fee Act (AGDUFA) program and suggestions regarding the features FDA should consider for the next reauthorization of the AGDUFA program. The meeting will be open to the public.
For more...